What are Insulin analog drugs?

Insulin analog drugs are pharmacologic agents that share a common mechanism (typically targeting Insulin receptor). 2 are currently marketed, with 5 more in clinical development.

What are the marketed Insulin analog drugs?

Marketed Insulin analog drugs include NPL insulin, Analog Insulin.

Insulin analog

2 marketed 4 in Phase 3 1 in Phase 2

This page covers all Insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor, Insulin receptor (INSR), insulin receptor.

Targets

Insulin receptor · Insulin receptor (INSR) · insulin receptor

Marketed (2)

NPL insulin · University of Campania Luigi Vanvitelli · Diabetes
NPL insulin is a long-acting basal insulin analog that binds to the insulin receptor to regulate blood glucose by promoting glucose uptake and storage in peripheral tissues.
Analog Insulin · National Institute of Neurosciences and Hospital, Dhaka · Diabetes
Analog insulin mimics endogenous insulin to regulate blood glucose by binding to insulin receptors and promoting glucose uptake in peripheral tissues.

Phase 3 pipeline (4)

insulin glulisin / insulin detemir · Sanofi · Diabetes
Insulin glulisine and insulin detemir work together to lower blood sugar levels by stimulating the uptake of glucose by cells.
glulisine insulin, glargine insulin · Population Health Research Institute · Diabetes
Glulisine insulin and glargine insulin are long-acting insulin analogs that mimic the action of human insulin, stimulating glucose uptake in cells and lowering blood glucose levels.
Mylan's insulin glargine · Mylan Inc. · Diabetes
Insulin glargine is a long-acting insulin analog that mimics the action of human insulin to lower blood glucose levels.
Viaject 7 · Biodel · Diabetes
Viaject 7 is a recombinant human insulin analog.

Phase 2 pipeline (1)

Buccal insulin spray · Generex Biotechnology Corp. · Diabetes
Insulin receptor agonist